An analysis of genetic data from over 900,000 people shows that certain stretches of DNA, made up of short sequences repeated ...

Applied Digital Corp (NASDAQ: APLD) shares are trending on Monday. Here’s a look at what you need to know. What To Know: Applied Digital has shifted its primary focus from hosting Bitcoin mining ...

Applied Digital announced it is raising $2.35 billion to fund the buildout of two additional data centers at its Polaris Forge campus in North Dakota. The two data centers will add a combined 250 ...

Applied Digital evolved from Bitcoin hosting to AI infrastructure, securing $16 billion in hyperscale leases across 600 MW of capacity. Fiscal Q1 2026 revenue jumped 84% to $64.2 million, signaling ...

Please submit your article to the Research Topic that best suits the focus of your research. The science of genetic epidemiology has been accelerated in recent years thanks to the advances of new ...

AI data center growth is constrained by capacity, creating a major opportunity for operators like Applied Digital to serve hyperscalers and HPC clients. Applied Digital's pivot to focus on ...

Applied Digital announced that its partner CoreWeave exercised a lease option for an additional 150 MW of computing power, bringing the total contract value to $11 billion. This is the maximum the ...

Base editors can correct disease-causing genetic variants. After a neonate had received a diagnosis of severe carbamoyl-phosphate synthetase 1 deficiency, a disease with an estimated 50% mortality in ...

Maria Rottersman of UC Davis holds a loaf of baked bread made using seed varieties developed without alpha-gliadin proteins, a component of gluten. (Alejandra Andrade / California Wheat Commission) ...

Applied Intuition announced Thursday it acquired EpiSci, the company whose software supported the Air Force's experimental X-62A VISTA last year in a dogfight with an F-16. (Richard Gonzales/Air Force ...

Nov 27 (Reuters) - Applied Therapeutics (APLT.O), opens new tab said on Wednesday that the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic metabolic disease, casting a ...